Literature DB >> 9680263

Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine.

P P Rowell1, D S Duggan.   

Abstract

Exposure of nicotinic acetylcholine receptors (nAChRs) to brief pulses of nicotine results in the stimulation of dopamine release, whereas prolonged treatment with low concentrations of nicotine (approximately 10 nM) produces a reversible blockade of a subsequent nicotine challenge as a result of nAChR desensitization. We and others have observed that, following prolonged treatment with stimulating (microM) concentrations of nicotine, there is incomplete recovery from desensitization. In this study we investigated this nonrecoverable component by characterizing the ability of nicotine to stimulate [3H]dopamine release from rat striatal synaptosomes following recovery from nicotine-induced desensitization. Brief (12 s) exposure to 30 microM nicotine, or longer exposure (> or = 5 min) to 0.3 microM nicotine produced a long-lasting decrease in nAChR function with an apparent IC50 of 0.7 microM. The maximal inactivation achieved was approximately 50%. Recovery of nAChR function did not return even after 5 h, whereas recovery from desensitization occurred within 20 min. Determinations of the concentration of nicotine in the superfusate indicated that residual nicotine could not account for the observed decrease in response as a consequence of desensitization. These results indicate that high concentrations of nicotine can produce a long-lasting nAChR inactivation which can be distinguished from reversible nAChR desensitization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680263     DOI: 10.1016/s0028-3908(97)00193-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures.

Authors:  T Seppä; M Ruotsalainen; I Laakso; R Tuominen; L Ahtee
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.

Authors:  O Salminen; T Seppä; H Gäddnäs; L Ahtee
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

Review 3.  Potential therapeutic uses of mecamylamine and its stereoisomers.

Authors:  Justin R Nickell; Vladimir P Grinevich; Kiran B Siripurapu; Andrew M Smith; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2013-04-18       Impact factor: 3.533

Review 4.  Molecular mechanisms underlying the motivational effects of nicotine.

Authors:  Darlene H Brunzell; Marina R Picciotto
Journal:  Nebr Symp Motiv       Date:  2009

Review 5.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

Review 6.  It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood.

Authors:  Marina R Picciotto; Nii A Addy; Yann S Mineur; Darlene H Brunzell
Journal:  Prog Neurobiol       Date:  2007-12-27       Impact factor: 11.685

Review 7.  Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

Authors:  Anitha P Govind; Paul Vezina; William N Green
Journal:  Biochem Pharmacol       Date:  2009-06-18       Impact factor: 5.858

Review 8.  Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Authors:  Jerry J Buccafusco; J Warren Beach; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2008-11-20       Impact factor: 4.030

9.  Neonicotinoid Insecticides Alter the Gene Expression Profile of Neuron-Enriched Cultures from Neonatal Rat Cerebellum.

Authors:  Junko Kimura-Kuroda; Yasumasa Nishito; Hiroko Yanagisawa; Yoichiro Kuroda; Yukari Komuta; Hitoshi Kawano; Masaharu Hayashi
Journal:  Int J Environ Res Public Health       Date:  2016-10-04       Impact factor: 3.390

10.  Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.

Authors:  G Batsikadze; W Paulus; A Hasan; J Grundey; M-F Kuo; M A Nitsche
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.